{"pmid":32327218,"title":"COVID-19 and rhinology: A look at the future.","text":["COVID-19 and rhinology: A look at the future.","The novel Coronavirus (COVID-19) has created a deadly pandemic that is now significantly impacting the United States. Otolaryngologists are considered high risk for contracting disease, as the virus resides in the nasal cavity, nasopharynx, and oropharynx. While valuable work has been publicized regarding several topics in Rhinology, we discuss other aspects of our specialty in further detail. There are several issues regarding Rhinologic practice that need to be clarified both for the current epidemic as well as for future expected \"waves.\" In addition, as the pandemic dies down, guidelines are needed to optimize safe practices as we start seeing more patients again. These include protocols pertinent to safety, in-office Rhinologic procedures, the substitution of imaging for endoscopy, and understanding the appropriate role of telemedicine. We discuss these aspects of Rhinology as well as practical concerns relating to telemedicine and billing, as these issues take on increasing importance for Rhinologists both in the present and the future.","Am J Otolaryngol","Setzen, Michael","Svider, Peter F","Pollock, Kim","32327218"],"abstract":["The novel Coronavirus (COVID-19) has created a deadly pandemic that is now significantly impacting the United States. Otolaryngologists are considered high risk for contracting disease, as the virus resides in the nasal cavity, nasopharynx, and oropharynx. While valuable work has been publicized regarding several topics in Rhinology, we discuss other aspects of our specialty in further detail. There are several issues regarding Rhinologic practice that need to be clarified both for the current epidemic as well as for future expected \"waves.\" In addition, as the pandemic dies down, guidelines are needed to optimize safe practices as we start seeing more patients again. These include protocols pertinent to safety, in-office Rhinologic procedures, the substitution of imaging for endoscopy, and understanding the appropriate role of telemedicine. We discuss these aspects of Rhinology as well as practical concerns relating to telemedicine and billing, as these issues take on increasing importance for Rhinologists both in the present and the future."],"journal":"Am J Otolaryngol","authors":["Setzen, Michael","Svider, Peter F","Pollock, Kim"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327218","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.amjoto.2020.102491","keywords":["covid-19","rhinology","telemedicine"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United States","Otolaryngologists"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664996914877169664,"score":8.518259,"similar":[{"pmid":32307192,"title":"Embracing telemedicine into your otolaryngology practice amid the COVID-19 crisis: An invited commentary.","text":["Embracing telemedicine into your otolaryngology practice amid the COVID-19 crisis: An invited commentary.","The COVID-19 pandemic has quickly and radically altered how Otolaryngologists provide patient care in the outpatient setting. Continuity of care with established patients as well as establishment of a professional relationship with new patients is challenging during this Public Health Emergency (PHE). Many geographic areas are under \"stay at home\" or \"shelter in place\" directives from state and local governments to avoid COVID-19 exposure risks. Medicare has recently allowed \"broad flexibilities to furnish services using remote communications technology to avoid exposure risks to health care providers, patients, and the community.\" [1] The implementation of telemedicine, or virtual, services, will help the Otolaryngologists provide needed care to patients while mitigating the clinical and financial impact of the pandemic. The significant coding and billing issues related to implementing telemedicine services are discussed to promote acceptance of this technology by the practicing Otolaryngologist. Of particular importance, outpatient visit Current Procedural Terminology(R) codes (99201-99215) may be used for telehealth visits performed in real-time audio and video.","Am J Otolaryngol","Pollock, Kim","Setzen, Michael","Svider, Peter F","32307192"],"abstract":["The COVID-19 pandemic has quickly and radically altered how Otolaryngologists provide patient care in the outpatient setting. Continuity of care with established patients as well as establishment of a professional relationship with new patients is challenging during this Public Health Emergency (PHE). Many geographic areas are under \"stay at home\" or \"shelter in place\" directives from state and local governments to avoid COVID-19 exposure risks. Medicare has recently allowed \"broad flexibilities to furnish services using remote communications technology to avoid exposure risks to health care providers, patients, and the community.\" [1] The implementation of telemedicine, or virtual, services, will help the Otolaryngologists provide needed care to patients while mitigating the clinical and financial impact of the pandemic. The significant coding and billing issues related to implementing telemedicine services are discussed to promote acceptance of this technology by the practicing Otolaryngologist. Of particular importance, outpatient visit Current Procedural Terminology(R) codes (99201-99215) may be used for telehealth visits performed in real-time audio and video."],"journal":"Am J Otolaryngol","authors":["Pollock, Kim","Setzen, Michael","Svider, Peter F"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307192","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.amjoto.2020.102490","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Otolaryngologists","Otolaryngologists","Otolaryngologist"],"_version_":1664632501541273600,"score":275.25314},{"pmid":32269598,"pmcid":"PMC7134577","title":"Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?","text":["Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?","There have been several reports noting anosmia and ageusia as possible symptoms of COVID-19. This is of particular interest in oncology since patients receiving some cancer treatments such as chemotherapy or immune therapy often experience similar symptoms as side-effects. The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians. Currently, there is no published evidence or case reports noting anosmia or ageusia as symptoms of COVID-19. Nevertheless, experts in rhinology have suggested that the onset of such symptoms could either act as a trigger for testing for the disease where possible, or could be a new criterion to self-isolate. Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anti-cancer therapy should contact their acute oncology support line for advice.","Ecancermedicalscience","Russell, Beth","Moss, Charlotte","Rigg, Anne","Hopkins, Claire","Papa, Sophie","Van Hemelrijck, Mieke","32269598"],"abstract":["There have been several reports noting anosmia and ageusia as possible symptoms of COVID-19. This is of particular interest in oncology since patients receiving some cancer treatments such as chemotherapy or immune therapy often experience similar symptoms as side-effects. The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians. Currently, there is no published evidence or case reports noting anosmia or ageusia as symptoms of COVID-19. Nevertheless, experts in rhinology have suggested that the onset of such symptoms could either act as a trigger for testing for the disease where possible, or could be a new criterion to self-isolate. Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anti-cancer therapy should contact their acute oncology support line for advice."],"journal":"Ecancermedicalscience","authors":["Russell, Beth","Moss, Charlotte","Rigg, Anne","Hopkins, Claire","Papa, Sophie","Van Hemelrijck, Mieke"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269598","week":"202015|Apr 06 - Apr 12","doi":"10.3332/ecancer.2020.ed98","keywords":["covid-19","ageusia","anosmia","smell","taste"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664637315727753217,"score":240.09467},{"pmid":32298480,"title":"Management of Infantile Hemangiomas during the COVID Pandemic.","text":["Management of Infantile Hemangiomas during the COVID Pandemic.","The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of infantile hemangiomas via telemedicine. FDA/EMA approved monitoring guidelines, clinical practice guidelines and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation are included. The importance of communication with caregivers in the context of telemedicine is discussed and online resources for both hemangioma education and for propranolol therapy provided.","Pediatr Dermatol","Frieden, Ilona J","Puttgen, Katherine B","Drolet, Beth A","Garzon, Maria C","Chamlin, Sarah L","Pope, Elena","Mancini, Anthony J","Lauren, Christine T","Mathes, Erin F","Siegel, Dawn H","Gupta, Deepti","Haggstrom, Anita N","Tollefson, Megha M","Baselga, Eulalia","Morel, Kimberly D","Shah, Sonal D","Holland, Kristen E","Adams, Denise M","Horii, Kimberly A","Newell, Brandon D","Powell, Julie","McCuaig, Catherine C","Nopper, Amy J","Metry, Denise W","Maguiness, Sheilagh","32298480"],"abstract":["The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of infantile hemangiomas via telemedicine. FDA/EMA approved monitoring guidelines, clinical practice guidelines and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation are included. The importance of communication with caregivers in the context of telemedicine is discussed and online resources for both hemangioma education and for propranolol therapy provided."],"journal":"Pediatr Dermatol","authors":["Frieden, Ilona J","Puttgen, Katherine B","Drolet, Beth A","Garzon, Maria C","Chamlin, Sarah L","Pope, Elena","Mancini, Anthony J","Lauren, Christine T","Mathes, Erin F","Siegel, Dawn H","Gupta, Deepti","Haggstrom, Anita N","Tollefson, Megha M","Baselga, Eulalia","Morel, Kimberly D","Shah, Sonal D","Holland, Kristen E","Adams, Denise M","Horii, Kimberly A","Newell, Brandon D","Powell, Julie","McCuaig, Catherine C","Nopper, Amy J","Metry, Denise W","Maguiness, Sheilagh"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298480","week":"202016|Apr 13 - Apr 19","doi":"10.1111/pde.14196","source":"PubMed","topics":["Prevention"],"weight":1,"e_drugs":["Propranolol"],"_version_":1664641388436783104,"score":209.35503},{"pmid":32297458,"title":"How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","text":["How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved.","PM R","Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K","32297458"],"abstract":["The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved."],"journal":"PM R","authors":["Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297458","week":"202016|Apr 13 - Apr 19","doi":"10.1002/pmrj.12380","keywords":["telemedicine","rehabilitation","telehealth","virtual visit"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664641388442025984,"score":194.03857},{"pmid":32238336,"pmcid":"PMC7124951","title":"Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","text":["Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine.","JMIR Public Health Surveill","Ohannessian, Robin","Duong, Tu Anh","Odone, Anna","32238336"],"abstract":["On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine."],"journal":"JMIR Public Health Surveill","authors":["Ohannessian, Robin","Duong, Tu Anh","Odone, Anna"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238336","week":"202014|Mar 30 - Apr 05","doi":"10.2196/18810","keywords":["covid-19","sars-cov-2","coronavirus","digital health","digital medicine","outbreak","pandemic","public health","surveillance","telehealth","telemedicine"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United Kingdom","Italy","France"],"countries":["United Kingdom","France","Italy"],"countries_codes":["GBR|United Kingdom","FRA|France","ITA|Italy"],"_version_":1664638354224840705,"score":186.06198}]}